First-in-Class Drug To Treat Cannabis Use Disorder Shows Great Promise in Clinical Trial
AEF0117, a first-in-class drug, has shown potential in treating cannabis use disorder (CUD) by inhibiting specific signals in cannabinoid receptors. ...
Read more